| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/20/1992 | WO1992013949A1 Nucleotide sequences coding for alpha chain variable regions in human lymphocyte receptors and applications thereof |
| 08/20/1992 | WO1992013948A1 Cloning of a new member of the fibroblast growth factor (fgf) receptor family |
| 08/20/1992 | WO1992013947A1 CD4-GAMMA2 AND CD4-IgG2 CHIMERAS |
| 08/20/1992 | WO1992013889A1 Nematode vaccine |
| 08/20/1992 | WO1992013888A1 Epithelial cell wound healing compositions and method |
| 08/20/1992 | WO1992013887A1 New cell adhesion peptides |
| 08/20/1992 | WO1992013885A1 MODIFIED INTERLEUKIN-1$g(b) |
| 08/20/1992 | WO1992013883A1 Lhrh antagonists |
| 08/20/1992 | WO1992013880A1 Novel peptide |
| 08/20/1992 | WO1992013879A1 Novel peptides with anticoagulatory effect |
| 08/20/1992 | WO1992013878A2 Conformationally restricted mimetics of beta turns and beta bulges and peptides containing the same |
| 08/20/1992 | WO1992013875A1 Improved blood substitute |
| 08/20/1992 | WO1992013874A2 Angiogenic peptides |
| 08/20/1992 | WO1992013870A1 Human platelet-derived growth factor receptors |
| 08/20/1992 | WO1992013867A1 Domains of extracellular region of human platelet derived growth factor receptor polypeptides |
| 08/20/1992 | WO1992013580A1 Enhanced suturing and means therefor |
| 08/20/1992 | WO1992013572A1 TECHNETIUM-99m LABELED POLYPEPTIDES FOR IMAGING |
| 08/20/1992 | WO1992013568A1 Vp6 encapsulated drug delivery |
| 08/20/1992 | WO1992013565A1 Growth factor containing matrix for the treatment of cartilage lesions |
| 08/20/1992 | WO1992013564A1 Combination of an angiotensin ii antagonist or renin inhibitor with a neutral endopeptidase inhibitor |
| 08/20/1992 | WO1992013562A1 An immunotoxin with in vivo t cell suppressant activity |
| 08/20/1992 | WO1992013561A1 Oxypurine nucleosides and their congeners, and acyl derivatives thereof, for improvement of hematopoiesis |
| 08/20/1992 | WO1992013559A1 CD4-GAMMA1 AND CD4-IgG1 CHIMERAS |
| 08/20/1992 | WO1992013556A1 Combination of igf-i and igfbp for anabolism |
| 08/20/1992 | WO1992013554A1 Method of treating benign and malignant proliferative skin disease |
| 08/20/1992 | WO1992013553A2 Method and agents for promoting wound healing |
| 08/20/1992 | WO1992013552A1 Anti-aggregatory peptides containing an aromatic ester or amide |
| 08/20/1992 | WO1992013551A1 Inhibition of multidrug transport by transforming growth factor beta and uses thereof |
| 08/20/1992 | WO1992013550A1 Recombinant transferrins, transferrin half-molecules and mutants thereof |
| 08/20/1992 | WO1992013549A1 Inhibition of cell proliferation by hydrophobic peptides |
| 08/20/1992 | WO1992013548A1 Method of inhibiting replication of hiv in macrophages |
| 08/20/1992 | WO1992013546A1 Mb-40 peptide that enhances the production of interleukin-1 and modulates age-associated immune response |
| 08/20/1992 | WO1992013544A1 Agent for preventing and treating viral myocarditis |
| 08/20/1992 | WO1992013526A1 Stabilisation of fibroblast growth factor using a polysaccharide |
| 08/20/1992 | WO1992013522A1 Orthomolecular method of treating sickle cell disease |
| 08/20/1992 | WO1992013495A1 Fibrinogen based adhesive |
| 08/20/1992 | WO1992007940A3 Bovine respiratory syncytial virus genes |
| 08/20/1992 | DE4136930A1 Verfahren zur herstellung einer pharmazeutischen zusammensetzung, die pharmazeutische zusammensetzung sowie deren verwendung A process for preparing a pharmaceutical composition, the pharmaceutical composition and the use thereof |
| 08/20/1992 | CA2103893A1 Monoclonal antibodies against receptor-induced binding sites |
| 08/20/1992 | CA2103676A1 Method and agents for promoting wound healing |
| 08/20/1992 | CA2103577A1 Conformationally restricted mimetics of beta turns and beta bulges and peptides containing the same |
| 08/20/1992 | CA2101735A1 Vp6 encapsulated drug delivery |
| 08/20/1992 | CA2101632A1 Human platelet-derived growth factor receptors |
| 08/20/1992 | CA2079896A1 Method of treating benign and malignant proliferative skin disease |
| 08/20/1992 | CA2079870A1 Vaccine |
| 08/20/1992 | CA2079461A1 Lhrh antagonists |
| 08/20/1992 | CA2061432A1 Cyclic hexapeptide compounds |
| 08/20/1992 | CA2060402A1 Topical use of calcitonin for the preparation of medications in senile idiopathic cataract and a pharmaceutical composition thereof |
| 08/19/1992 | EP0499348A1 Ovulation-inhibiting agent for hormonal contraception |
| 08/19/1992 | EP0499266A1 Endothelin antagonist |
| 08/19/1992 | EP0499242A1 Stimulation of endosteal bone formation with a cell growth factor |
| 08/19/1992 | EP0499164A1 Injectable compositions to replace lubricating body fluids |
| 08/19/1992 | EP0499162A2 GM-CSF inhibiting oligopeptides |
| 08/19/1992 | EP0499161A2 GM-CSF inhibiting antibodies |
| 08/19/1992 | EP0499112A1 Antibodies against an IgE receptor |
| 08/19/1992 | EP0499080A2 Aminoacid derivatibes |
| 08/19/1992 | EP0498941A2 Peptide skeletal muscle relaxants |
| 08/19/1992 | EP0498940A2 Peptide amides and amide dimers |
| 08/19/1992 | EP0498856A1 Inhibitor of laminin neurite promoting activity |
| 08/19/1992 | EP0498854A1 Antivenoms and methods for making antivenoms |
| 08/19/1992 | EP0478627A4 Co-expression of heteromeric receptors |
| 08/19/1992 | EP0472638A4 Method for isolating receptors having a preselected specificity |
| 08/19/1992 | EP0449956A4 Novel lymphokine/cytokine genes |
| 08/19/1992 | EP0425661A4 A new method for tapping the immunological repertoire |
| 08/19/1992 | EP0340245B1 Substituted alkylamides of teicoplanin compounds |
| 08/19/1992 | EP0315627B1 A method to treat blood |
| 08/19/1992 | EP0305401B1 Combinations having synergistic growth hormone releasing activity and methods for use thereof |
| 08/19/1992 | EP0288478B1 Use of growth hormone for nitrogen retention under hypocaloric conditions |
| 08/19/1992 | EP0153961B1 Recombinant materials and methods for producing human connective tissue-activating peptide-iii and analogs thereof |
| 08/19/1992 | CN1063691A Amino acid derivatives process for preparation thereof and pharmaceutical composition comprising same |
| 08/18/1992 | US5140105 Purified and isolated HIV protein; reacts with monoclonal anti-monoclonal-anti-human lymphocyte T4 antibodies |
| 08/18/1992 | US5140103 Quanitative analysis of telopeptides crosslinked by hydroxylysyl pyridinoline(HP) or lysyl pyridinoline(LP) derived from bone collagen reabsorption |
| 08/18/1992 | US5140102 Controls intestinal fluid absorption |
| 08/18/1992 | US5140100 Isolated from human decidual cells with molecular weight of from 7000 to 10000 daltons |
| 08/18/1992 | US5140048 Aging resistance in animals; food preservatives; administering a carboxyl-containing hydrazide; preventing glycosylation of proteins |
| 08/18/1992 | US5140012 Method for preventing onset of restenosis after angioplasty employing pravastatin |
| 08/18/1992 | US5140011 Hypotensive agents |
| 08/18/1992 | US5140010 Stabilized aqueous formulations of thymopentin |
| 08/18/1992 | US5140009 Stable against proteolytic enzymes; anticarcinogenic agents; urogenital disorders |
| 08/18/1992 | US5140008 Human growth hormone unit dose for the treatment of intoxicated individuals |
| 08/18/1992 | US5139947 Antigenic noninfectious hiv-producing cloned t cell |
| 08/18/1992 | US5139944 Collagen-specific enzyme with platelet aggregation inhibition properties |
| 08/18/1992 | US5139778 Antibiotic ge 2270 factors a1, a2, a3 and h |
| 08/18/1992 | CA1306583C Pasteurizable, freeze-driable hemoglobin-based blood substitute |
| 08/18/1992 | CA1306581C Platelet binding inhibitors |
| 08/18/1992 | CA1306580C 3-halovinylglycine antibacterial agents |
| 08/18/1992 | CA1306568C Negative photoresist based on polyphenols and epoxy compounds or vinyl ethers |
| 08/18/1992 | CA1306430C Monoclonal antibody |
| 08/16/1992 | CA2061246A1 Peptides having antagonistic activities to endothelin receptors, production and use thereof |
| 08/16/1992 | CA2061211A1 Stimulation of endosteal bone formation |
| 08/15/1992 | WO1992014755A1 A NOVEL INTEGRIN SPECIFICITY FOR THE HIV Tat PROTEIN |
| 08/15/1992 | CA2101919A1 Integrin specificity for the hiv tat protein |
| 08/14/1992 | CA2054651A1 Peptide amides and amide dimers |
| 08/14/1992 | CA2054627A1 Polypeptide skeletal muscle relaxants |
| 08/13/1992 | WO1992013881A1 Peptides |
| 08/13/1992 | WO1992013560A1 Reagents and methods for identification of vaccines |
| 08/13/1992 | DE4104240A1 Klonierung eines neuen mitgliedes der familie der fibroblasten-wachstumsfaktoren (fgf)-rezeptoren Receptors cloning of a new member of the family of fibroblast growth factors (FGF) |
| 08/13/1992 | DE4103649A1 Neue antikoagulatorisch wirksame peptide New anticoagulatory peptide |
| 08/13/1992 | CA2103788A1 Reagents and methods for identification of vaccines |
| 08/13/1992 | CA2103703A1 Peptides |